132224-93-2 Usage
General Description
2-(4-Cyano-Phenyl)ethylamine is an organic chemical compound, belonging to the group of aromatic primary amines. The structure of this compound consists of a two-carbon chain (ethyl) bound to an amine group at one end and a phenyl group, which is further substituted by a cyano group, on the other end. This substance is of particular interest in the field of organic chemistry, often used in the production of polymers, dyes, and pharmaceuticals. However, like many chemical substances, 2-(4-Cyano-Phenyl)ethylamine may pose safety risks if not handled properly. It is thus advised to have appropriate safeguards in place when working with this compound.
Check Digit Verification of cas no
The CAS Registry Mumber 132224-93-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,2,2,2 and 4 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 132224-93:
(8*1)+(7*3)+(6*2)+(5*2)+(4*2)+(3*4)+(2*9)+(1*3)=92
92 % 10 = 2
So 132224-93-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H10N2/c10-6-5-8-1-3-9(7-11)4-2-8/h1-4H,5-6,10H2
132224-93-2Relevant articles and documents
TRIAZOLOTRIAZINE DERIVATIVES AS A2A RECEPTOR ANTAGONISTS
-
, (2020/01/24)
The present invention provides triazolotriazine derivatives of formula (1) as A2A receptor antagonists. Compounds of formula (1) and pharmaceutical compositions including the compounds can be used for the treatment of disorders related to A2A receptor hyp
Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines
Dianati, Vahid,Kwiatkowska, Anna,Couture, Frédéric,Desjardins, Roxane,Dory, Yves L.,Day, Robert
, p. 8457 - 8467 (2018/09/27)
The serine protease, PACE4, is a proprotein convertase that plays a substantial role in malignancy of prostate cancer. Our initial selective PACE4 inhibitor (Ac-LLLLRVKR-NH2) has evolved to the current lead compound C23 (Ac-dLeu-LLLRVK-Amba), w
Methods and compositions for treating pain
-
Page/Page column 47, (2010/11/28)
The present application relates to compounds and methods for treating pain, incontinence and other conditions.